Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lactate-13C is a stable isotope-labeled small molecule tracer used as a diagnostic and research tool to study lactate metabolism in vivo. Developed by **Karolinska University Hospital** in collaboration with **Karolinska Institutet**, it is administered as an intravenous bolus to measure lactate appearance and clearance rates (lactate kinetics) using non-compartmental pharmacokinetic modeling. Unlike radioactive tracers, 13C is a stable carbon isotope, making it suitable for clinical research in sensitive populations. The compound is primarily utilized to investigate metabolic dysfunction in critically ill patients, such as those suffering from sepsis or septic shock in the intensive care unit (ICU). It serves as a probe for the endogenous lactate metabolic pathway rather than a therapeutic agent.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lactate-13C.